NERVGEN PHARMA ORD's ticker is NGENF and the CUSIP is 64082X203. A total of 1 filers reported holding NERVGEN PHARMA ORD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4 | 0.0% | 3,400 | 0.0% | 0.00% | -60.0% |
| Q2 2023 | $4 | 0.0% | 3,400 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $4 | 0.0% | 3,400 | 0.0% | 0.01% | -16.7% |
| Q4 2022 | $4 | -99.9% | 3,400 | 0.0% | 0.01% | +100.0% |
| Q3 2022 | $4,000 | -20.0% | 3,400 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $5,000 | +25.0% | 3,400 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $4,000 | -33.3% | 3,400 | +13.3% | 0.00% | +33.3% |
| Q4 2021 | $6,000 | -50.0% | 3,000 | -53.8% | 0.00% | -50.0% |
| Q3 2021 | $12,000 | -52.0% | 6,500 | -67.5% | 0.01% | -40.0% |
| Q2 2021 | $25,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FNY Investment Advisers, LLC | 20,000 | $25,000 | 0.01% |